menu search

Investor alert: abbott cooper pllc announces investigation into zentalis pharmaceuticals, inc.; urges zentalis stockholders to contact abbott cooper regarding their legal rights

STAMFORD, Conn., Nov. 04, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating zentalis Pharma...

November 4, 2023, 3:53 pm

zentalis: a buy as small molecule trials continue to advance

zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing targeted c...

August 24, 2023, 9:42 am

Matrix capital infuses $108 million into zentalis toward promising cancer therapeutics

Shares of zentalis Pharmaceuticals Inc (US:ZNTL) are cooling off a bit Thursday after yesterday's 4% ri...

June 22, 2023, 10:21 pm

Why shares of zentalis pharmaceuticals dropped this week

zentalis is a clinical-stage biotech that is focusing on cancer therapies. The stock is up more than 29...

June 2, 2023, 2:34 pm

zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including clinical support for cyclin e1 expression as predictive marker for clinical benefit from

Builds on recent preclinical data presented at AACR supporting the use of CCNE1 amplification and / or Cyclin E1 expression as a potential marker for ...

April 26, 2023, 10:00 am

zentalis pharmaceuticals to participate in two upcoming investor conferences

NEW YORK and SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL)...

February 1, 2023, 7:01 am

zentalis pharmaceuticals, inc. (zntl) upgraded to buy: here's what you should know

zentalis Pharmaceuticals, Inc. (ZNTL) might move higher on growing optimism about its earnings prospect...

August 26, 2022, 1:33 pm

Pfizer injects $25m via equity in zentalis pharma

zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) will sell 953,834 common shares at $26.21 per share to Pf...

April 27, 2022, 10:19 am


Search within

Pages Search Results: